Breaking:
Rashmika Mandanna, Vijay Deverakonda File Cyber Complaint India’s New Privacy Law Could Shut Down Newsrooms, Publishers Warn NBEMS Revises First-Year Fees for NEET PG 2026 Admissions NTA Revises Exam Calendar for December 2026 to April 2027 Key October 26: Cyberterrorism, PM-KUSUM and More Agrivoltaics in India: UPSC GS 3 Practice Questions
Quick Read Web Stories Games & Puzzles Search
Divine Media 24 News Worth Reading
Tuesday, October 27, 2026
AdvertisementThe Puranic
Home » Topic

immuno-oncology India

Dr Reddy’s Launches Nivorz in India’s Biosimilar Market Health

Dr Reddy’s Launches Nivorz in India’s Biosimilar Market

Dr Reddy’s enters India’s biosimilar immuno-oncology market with Nivorz, a biosimilar of nivolumab, developed and manufactured at its Hyderabad facility.

By Divine Media 24·1 month ago
Your choice about your data

This site needs a couple of cookies to work at all, and those are always on. Beyond that, nothing loads unless you say so. You can change your mind at any time, and saying no costs you nothing on this site. Read the privacy notice for the detail.

Choose for each purpose